I feel compelled to rebut several misrepresentations made by Mark Case, BGE’s vice president of regulatory policy, in a recent article, “Electrification will strain Maryland’s grid. The question is by ...
Primary Sclerosing Cholangitis (PSC) is a debilitating rare disease of the liver with no effective treatment. Reported in Nature Genetics researchers from the Wellcome Trust Sanger Institute, Mayo ...
SAN FRANCISCO--(BUSINESS WIRE)--Perspectum announced recruitment of the first patient in a multi-center collaborative study to characterize Primary Sclerosing Cholangitis in children, “Prospective ...
Table 1 Association summary statistics across four newly associated PSC risk loci In summary, we performed the largest genome-wide association study of PSC to date and identified four new PSC risk ...
The last time I spoke about Mirum Pharmaceuticals, Inc. (MIRM) it was in a Seeking Alpha article entitled "Mirum Pharmaceuticals: After Phase 2 Miss, An iBAT Inhibitor On Deck To Drive Value." With ...
Phase I study of weekly outpatient paclitaxel and concurrent cranial irradiation in adults with astrocytomas. Thirty-four patients were treated with 53 cycles of PSC 833 and etoposide. Steady-state ...
Primary Sclerosing Cholangitis (PSC) is a debilitating rare disease of the liver with no effective treatment. Researchers have now identified four regions of the genome associated with the disease, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results